Use of Integra and interval brachytherapy in a 2-stage auricular reconstruction after excision of a recurrent keloid.
Use of Integra and interval brachytherapy in a 2-stage auricular reconstruction after excision of a recurrent keloid.
复制标题
在切除复发性瘢痕疙瘩后进行两阶段耳廓重建中使用 Integra 和间隔近距离放射治疗。
DOI:
10.1097/scs.0b013e3182587388
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
Spector,JasonA
中科院分区:
文献类型:
--
作者:
Reiffel,AlyssaJ;Sohn,AllieM;Henderson,PeterW;Fullerton,Natalia;Spector,JasonA
Keloids present a formidable clinical challenge. Surgical excision in conjunction with radiation therapy may decrease the chance of keloid recurrence. Split-thickness skin grafts, however, are more prone to failure in the setting of radiation. In this report, we present a patient with a recurrent auricular keloid who underwent excision and immediate Integra (Integra LifeSciences, Plainsboro, NJ) application, followed by high–dose rate brachytherapy and interval split-thickness skin graft placement. A 23-year-old woman with a history of a recurrent auricular keloid after previous surgical excision, corticosteroid injection, and radiation underwent reexcision of her keloid. Integra was used to cover the resultant exposed auricular perichondrium. The patient then received high–dose rate brachytherapy (1500 cGy) on postoperative days 1 and 2, followed by definitive split-thickness skin graft placement 3 weeks after her initial surgery. The patient recovered from all interventions without complication. There was no evidence of keloid formation 27 months after the interval split-thickness skin graft placement at either the auricular recipient or thigh donor sites. We report the first case of a 2-stage reconstruction of a recurrent auricular keloid (composed of keloid excision and placement of Integra in conjunction with high–dose rate brachytherapy, followed by interval split-thickness skin grafting), resulting in an acceptable cosmetic result without evidence of recurrence at long-term follow-up.